Formulation de diltiazem à absorption controllée

European patent · EP0320097 · Deleted

Register entry

Publication number
EP0320097
Application number
EP88309665
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 14, 1988
Published
Jun 14, 1989
Granted
Jun 4, 2003
Deleted
Oct 13, 2008
Reason
Maximum term reached
IPC classes
A61K 31/55 (2006.01)
A61K 9/00 (2006.01)
A61P 9/10 (2006.01)
Priority
IE 279087 16.10.1987
IE 279187 16.10.1987
IE 315887 20.11.1987
IE 82288 18.03.1988
Divided from
EP98105888
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 20, 2008

    Maximum term reached

    Published in Swissreg on 20.10.2008

  2. Sep 30, 2003

    Agent entered

    Representative
    Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

    Published in +pat+ No 18 in 2003

  3. Jun 13, 2003

    Granted

    Published in +pat+ No 11 in 2003

Parties

Holder

Elan Corporation, Plc.

ELAN CORPORATION, Plc

Lincoln House, Lincoln Place, Dublin 2, IE

Agent

Patentanwälte Schaad, Balass, Menzl & Partner AG

Dufourstrasse 101, 8034 Zürich

Inventor

Geoghegan, Edward James

Athlone County Westmeath, IE

Mulligan, Seamus

Athlone County Westmeath, IE

Panoz, Donald Eugene

Tuckerstown Bermuda, IE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.